TRANSPLANT Flashcards
Class I HLA antigen are found on what cells
all nucleated cells
Class II HLA are found on wet cells
antigen presenting cells: Macrophage Dendritic cells B. lymphocytes Monocytes
corticosteroid
use, mechanism, side effects
maintenance, rejection
IL1 released
Posttransplant diabetes, hypertension, osteonecrosis, Cushing’s
azathioprine
use, mechanism, side effects
maintenance
Azathioprine (purine) block
Inhibits nuclaic acid syntheis (DNA) - the we will do him suppressing proliferation of activated B and T-cells
bone marrow depression, hepatic venoocclusive disease, pancreatitis, RBC achalasia, arthralgia
cyclosporine
use, mechanism, side effects
maintenance
C=C CALCINEURIN cyst is in
L2 secretion and formation inhibition
Inhibits calcineurin
Nephrotoxic-interstitial fibrosis and arteriolar lesions blood Hepatotoxicity Hypertension Hyperkalemia Hirsutism Gingival hyperplasia Tremors Headache
drug inhibits IL-2 synthesis
tacrolimus
tacrolimus
use, mechanism, side effects
(FK506, Prograft)
maintenance refractory rejection (rescue)
IL-2 synth / production
Nephrotoxic
Glucose intolerance
Neuro toxic
hypertension
mycophenolate mofetil
use, mechanism, side effects
(CellCept)
Maintenance
Inosine monophosphate dehydrogenase inhibition
Neutropenia
GI
Sirolimus
use, mechanism, side effects
maintenance
TOR inhibitor
( target of rapamycin)
THROMBOCYTOPENIA
neutropenia
Impaired wound healing
Dyslipidemia
OKT3
use, mechanism, side effects
(Monoclonal antibody)
treatment of rejection
Depletion of T cells
receptors surface T-cell
fever/chills
Pulmonary edema
LYMPHOPROLIFERATIVE disorder
Polyclonal anti-lymphocyte
use, mechanism, side effects a
induction therapy
treatment of rejection
Decreased lymphocytes
ANAPHYLAXIS Leukopenia Thrombocytopenia LYMPHOPROLIFERATIVE disorder cytokine release syndrome Fever
Daclizumab and Basiliximab
induction therapy
IL2 receptor blockade
Minimal
how does cyclosporine inhibit T-cell activation
inhibit calcineurin As primary mechanism secondary effect is IL-2
University of Wisconsin solution
raffinose
hydroxyethyl starts
lactobionate
rejection and start on postoperative day 2
accelerated acute rejection
Hyperacute rejection
minutes to hours
Antibody mediated
Preformed antibiotics to ABO blood blood group or HLA antigens
In the field and necrosis Vascular thromboses Flaccid Cyanotic anuric PMNs packed and peri-capillary
Accelerated acute rejection
Days
Memory response to prior sensitization
Rare difficult to control
Early graft loss
Cellular and antibody mediated injury
More, and went recipient has been sensitized by previous antigen exposure
Kidney-oliguria
disseminated intravascular coagulation
Thrombocytopenia
Hemolysis
Swollen organ
Tender
Congestive
Arterial necrosis
Perry vasculitis
Glomerular basement membrane CD4 deposition
acute rejection
days to months
Predominantly cell-mediated:
Lymphocytes
Chronic rejection
slow progressive of months to years
Immune and nonimmune mechanisms involved
Vascular intimal hyperplasia
Lymphocytic infiltration
Atrophy
Fibrosis
Delayed type hypersensitivity
Chronic ischemia
Antibiotic formation
Causing her inhibitor toxicity is a risk
TGF beta may be a risk
the most significant side effect of s sirolimus
thrombocytopenia
Other side effects:
Neutropenia
Impaired wound healing
Increased lipids
cyclosporine levels are affected by what drugs
p450 complication
Inducers of the P450 system
Phenytoin ramp up p450
Inhibitors or competitive ears with the P450 system
Inhibitors or competitive ears with the P450 system
Erythromycin
Cimetidine
Ketoconazole
Fluconazole
Living donor bowel is removed for transplant
How much length
was blood supply
mid ileum to distal ileum-the good part
This is about 200 cm
ileocolic vessels